|
|
Volumn 2, Issue 9, 2002, Pages 939-971
|
|
Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AKT1 PROTEIN, HUMAN;
ANTINEOPLASTIC AGENT;
CHECKPOINT KINASE 1;
ENZYME INHIBITOR;
ONCOPROTEIN;
PROTEIN KINASE;
PROTEIN KINASE B;
PROTEIN KINASE INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
AMINO ACID SEQUENCE;
ANIMAL;
CELL CYCLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DNA DAMAGE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
GENETICS;
HUMAN;
METABOLISM;
MOLECULAR GENETICS;
NEOPLASM;
REVIEW;
SEQUENCE HOMOLOGY;
AMINO ACID SEQUENCE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
DNA DAMAGE;
ENZYME INHIBITORS;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR SEQUENCE DATA;
NEOPLASMS;
PROTEIN KINASE INHIBITORS;
PROTEIN KINASES;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-AKT;
SEQUENCE HOMOLOGY, AMINO ACID;
|
|
EID: 0036718911
PISSN: 15680266
EISSN: None
Source Type: Journal
DOI: 10.2174/1568026023393318 Document Type: Review |
|
Times cited : (123)
|
|
References (271)
|
